Effect of Diabetes Mellitus on Complication Rates of Coronary Artery Bypass Grafting

被引:8
作者
Brush, John E., Jr. [1 ,2 ]
Siraj, Elias S. [1 ]
Kemp, Clinton D. [1 ,2 ]
Liverman, Deborah P. [2 ]
McMichael, Brittany Y. [2 ]
Lamichhane, Rajan [1 ]
Sheehan, Brynn E. [1 ]
机构
[1] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[2] Sentara Healthcare, Norfolk, VA 23502 USA
关键词
CARDIOVASCULAR-DISEASE; SURGERY; SOCIETY; REVASCULARIZATION; DRUGS;
D O I
10.1016/j.amjcard.2019.07.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have shown that diabetes mellitus (DM) is a risk factor for postoperative coronary artery bypass grafting (CABG) complications. More contemporary studies are needed to guide revascularization decisions in DM patients. We performed a single-center study of patients who underwent CABG. Patients with no DM were compared with patients with DM, subgrouped according to whether or not DM was treated with insulin before admission (Insulin and No Insulin Groups). Multivariable logistic regression was used to determine whether DM was a significant predictor of mortality, combined postoperative events, and specific postoperative complications after controlling for other predictive clinical variables. Of 11,590 consecutive patients who underwent CABG, 5,013 (43%) had DM and 6,577 (57%) had no DM. Of the patients with DM, 3,433 (68%) were not treated with insulin and 1,580 (32%) were treated with insulin before admission. Multivariable logistic regression analyses showed that DM was not significantly associated with in-hospital mortality or combined postoperative events after considering other clinical variables. The No Insulin Group was significantly associated with stroke, and the Insulin Group was significantly associated with surgical site infection and new renal failure. In conclusion, this study of consecutively treated CABG patients shows that DM is not a predictor of in-hospital mortality or combined in-hospital postoperative events after adjusting for other clinical factors. DM is a predictor of permanent stroke, surgical site infection, and new renal failure. These findings may help with case selection and management of DM patients undergoing CABG. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 21 条
[1]  
Alderman EL, 1996, NEW ENGL J MED, V335, P217
[2]   Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery [J].
Alserius, Thomas ;
Anderson, Russell E. ;
Hammar, Niklas ;
Nordqvist, Tobias ;
Ivert, Torbjorn .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2008, 42 (06) :392-398
[3]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[4]  
Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[5]   Diabetes mellitus, race, and socioeconomic status - A population based study [J].
Brancati, FL ;
Whelton, PK ;
Kuller, LH ;
Klag, MJ .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (01) :67-73
[6]   Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery [J].
Carson, JL ;
Scholz, PM ;
Chen, AY ;
Peterson, ED ;
Gold, J ;
Schneider, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :418-423
[7]   Strategies for Multivessel Revascularization in Patients with Diabetes [J].
Farkouh, Michael E. ;
Domanski, Michael ;
Sleeper, Lynn A. ;
Siami, Flora S. ;
Dangas, George ;
Mack, Michael ;
Yang, May ;
Cohen, David J. ;
Rosenberg, Yves ;
Solomon, Scott D. ;
Desai, Akshay S. ;
Gersh, Bernard J. ;
Magnuson, Elizabeth A. ;
Lansky, Alexandra ;
Boineau, Robin ;
Weinberger, Jesse ;
Ramanathan, Krishnan ;
Sousa, J. Eduardo ;
Rankin, Jamie ;
Bhargava, Balram ;
Buse, John ;
Hueb, Whady ;
Smith, Craig R. ;
Muratov, Victoria ;
Bansilal, Sameer ;
King, Spencer, III ;
Bertrand, Michel ;
Fuster, Valentin .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2375-2384
[8]   Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes [J].
Ferrannini, Ele ;
DeFronzo, Ralph A. .
EUROPEAN HEART JOURNAL, 2015, 36 (34) :2288-U19
[9]  
Filsoufi Farzan, 2007, Interact Cardiovasc Thorac Surg, V6, P753
[10]   Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012 [J].
Geiss, Linda S. ;
Wang, Jing ;
Cheng, Yiling J. ;
Thompson, Theodore J. ;
Barker, Lawrence ;
Li, Yanfeng ;
Albright, Ann L. ;
Gregg, Edward W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (12) :1218-1226